Angiotensin inhibition and cellular senescence in the developing rat kidney

被引:3
|
作者
Yoo, Kee Hwan [1 ]
Yim, Hyung Eun [1 ]
Bae, Eun Soo [1 ]
机构
[1] Korea Univ, Coll Med, Dept Pediat, Seoul 02841, South Korea
关键词
Apoptosis; Cellular senescence; Fetal development; Kidney; Renin-angiotensin system; CONVERTING ENZYME-INHIBITION; BLOOD-PRESSURE; RENIN; SYSTEM; EXPRESSION; CELLS; TELOMERASE; INDUCTION; APOPTOSIS; CANCER;
D O I
10.1016/j.yexmp.2020.104551
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Cellular senescence is important for the maintenance of tissue homeostasis during normal development. In this study, we aimed to investigate the effect of renin angiotensin system (RAS) blockade on renal cell senescence in the developing rat kidney. Newborn rat pups were treated with enalapril (30 mg/kg/day) or vehicle for seven days after birth. We investigated the intrarenal expressions of cell cycle regulators p21 and p16 with immunoblots and immunohistochemistry at postnatal day 8. For the determination of renal cellular senescence, immunostaining for senescence-associated beta-galactosidase (SA-beta-gal) and telomerase reverse transcriptase (TERT) was also performed. Enalapril treatment showed significant alterations in cellular senescence in neonatal rat kidneys. In the enalapril-treated group, intrarenal p16 and p21 protein expressions decreased compared to controls. The expressions of both p21 and p16 were reduced throughout the renal cortex and medulla of enalapril-treated rats. The immunoreactivity of TERT in enalapril-treated kidneys was also weaker than that in control kidneys. Control kidneys revealed a clear positive SA-beta-gal signal in the cortical tubules; however, SA-beta-gal activity was noticeably lower in the enalapril-treated kidneys than in control kidneys. Interruption of the RAS during postnatal nephrogenesis may disrupt physiologic renal cellular senescence in the developing rat kidney.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Angiotensin-Converting Enzyme Inhibition Decreases Growth Factor Expression in the Neonatal Rat Kidney
    Kee Hwan Yoo
    Jennifer T Wolstenholme
    Robert L Chevalier
    Pediatric Research, 1997, 42 : 588 - 592
  • [42] Angiotensin converting enzyme inhibition decreases growth factors expression in the neonatal rat kidney.
    Yoo, KH
    Chevalier, RL
    KIDNEY INTERNATIONAL, 1998, 54 (05) : 1789 - 1789
  • [43] Role of sodium/glucose cotransporter inhibition on a rat model of angiotensin II–dependent kidney damage
    Humberto Reyes-Pardo
    Rocío Bautista
    Hilda Vargas-Robles
    Amelia Rios
    Daniel Sánchez
    Bruno Escalante
    BMC Nephrology, 20
  • [44] Cellular senescence contributes to spontaneous repair of the rat meniscus
    Aimono, Yusuke
    Endo, Kentaro
    Sekiya, Ichiro
    AGING CELL, 2025, 24 (02)
  • [45] Ageing, cellular senescence and chronic kidney disease: experimental evidence
    Tan, Huishi
    Xu, Jie
    Liu, Youhua
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2022, 31 (03): : 235 - 243
  • [46] Accelerated cellular senescence in the kidney: cause or effect of disease progression?
    Phillips, Carrie L.
    TRANSLATIONAL RESEARCH, 2012, 159 (06) : 419 - 420
  • [47] Cellular Senescence in Kidney Fibrosis: Pathologic Significance and Therapeutic Strategies
    Xu, Jie
    Zhou, Lili
    Liu, Youhua
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [48] Aldosterone/Mineralocorticoid Receptor Stimulation Induces Cellular Senescence in the Kidney
    Fan, Yu-Yan
    Kohno, Masakazu
    Hitomi, Hirofumi
    Kitada, Kento
    Fujisawa, Yoshihide
    Yatabe, Junichi
    Yatabe, Midori
    Felder, Robin A.
    Ohsaki, Hiroyuki
    Rafiq, Kazi
    Sherajee, Shamshad J.
    Noma, Takahisa
    Nishiyama, Akira
    Nakano, Daisuke
    ENDOCRINOLOGY, 2011, 152 (02) : 680 - 688
  • [49] Cellular Senescence in Metabolic-Associated Kidney Disease: An Update
    Gao, Pan
    Zou, Xingjian
    Sun, Xin
    Zhang, Chun
    CELLS, 2022, 11 (21)
  • [50] Cellular Senescence and Senotherapies in the Kidney: Current Evidence and Future Directions
    Docherty, Marie Helena
    Baird, David P.
    Hughes, Jeremy
    Ferenbach, David A.
    FRONTIERS IN PHARMACOLOGY, 2020, 11